Changes in the endogenous opioid system (physiological increases in plasma beta-endorphin concentrations under stress conditions) may play a role in some metabolic alterations associated with obesity, including hyperglycaemia and hyperinsulinemia [33,34]. This evidence concerns the gene POMC and obesity due to melanocortin 4 receptor deficiency.